Biotech · Private company
Agendia
Track this companyFree. Adds Agendia to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BluePrint 80 gene expression profileBreast CancerClinicalTrials.gov · fetched Nov 12, 2026
- MammaPrint 70-gene expression profileBreast CancerClinicalTrials.gov · fetched Nov 12, 2026
- MammaPrint, BluePrint, and Full-Genome TestingBreast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Gene Signatures to Guide HR+MBC Therapy in a Diverse CohortPHASE2 · RECRUITING · started Sep 28, 2023ClinicalTrials.gov NCT05693766 · fetched Nov 12, 2026
- The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast CancerPHASE2 · COMPLETED · started Feb 20, 2019ClinicalTrials.gov NCT04129216 · fetched Nov 12, 2026
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRECRUITING · started Apr 28, 2017ClinicalTrials.gov NCT03053193 · fetched Nov 12, 2026
- The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer PatientsCOMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT02669745 · fetched Nov 12, 2026
- NBRST: Prospective Neo-adjuvant REGISTRY TrialCOMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01479101 · fetched Nov 12, 2026
- A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintUNKNOWN · started Sep 1, 2008ClinicalTrials.gov NCT00903565 · fetched Nov 12, 2026